Clinical Trials Directory

Trials / Completed

CompletedNCT00906295

Establishment of Optimal Transfusion Threshold After Major Orthopedic Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
67 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether a higher threshold for transfusion with red blood cells improves the postoperative ambulation.

Conditions

Interventions

TypeNameDescription
OTHERAllowed drop in hemoglobin to 4.5-5.5 mmol/LTransfusion with red blood cells to hemoglobin between 4.5-5.5 mmol/L (Transfusion threshold of 4.5 mmol/L)
OTHERAllowed drop in hemoglobin to level between 5.6-6.5 mmol/LTransfusion with red blood cells to between hemoglobin 5.6-6.5 mmol/L (Transfusion threshold of 5.5 mmol/L)

Timeline

Start date
2009-06-01
Primary completion
2011-05-01
Completion
2011-06-01
First posted
2009-05-21
Last updated
2011-06-06

Locations

2 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00906295. Inclusion in this directory is not an endorsement.